These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 13937539)
21. [Treatment of coronary insufficiency with Persantin]. RIEGLER E Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533 [No Abstract] [Full Text] [Related]
22. [CHEMISTRY OF CARDIAC DRUGS]. KNABE J Med Monatsschr; 1964 Feb; 18():54-8. PubMed ID: 14165991 [No Abstract] [Full Text] [Related]
23. [Treatment of coronary insufficiency with 2, 6-bis(diethylamino)-4, 8-dipiperidino-pyrimido(5, 4-d)pyrimidine (persantin)]. LANG O Wien Med Wochenschr; 1959 Dec; 109():1006-7. PubMed ID: 14413872 [No Abstract] [Full Text] [Related]
26. [Coronary dilators]. Ilic-Vukotić M Med Arh; 1972; 26(2):81-4. PubMed ID: 4402269 [No Abstract] [Full Text] [Related]
27. [Evaluation of the activity of p-chlorophenoxyacetic acid isopropylhydrazide (Sinderesin) in the treatment of coronary insufficiency]. NIGRO G; ESPOSITO R; COMI LI Riforma Med; 1963 Mar; 77():228-31. PubMed ID: 13938597 [No Abstract] [Full Text] [Related]
28. [CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY]. MENCI S Gazz Int Med Chir; 1964 Jan; 68():98-109. PubMed ID: 14123796 [No Abstract] [Full Text] [Related]
29. [Results of a double blind study with segontin--digoxin in coronary heart disease. (author's transl)]. Nossen J MMW Munch Med Wochenschr; 1977 Feb; 119(5):159-62. PubMed ID: 402568 [TBL] [Abstract][Full Text] [Related]
31. [Longterm treatment of coronary heart disease with Segontin (author's transl)]. Schütz E MMW Munch Med Wochenschr; 1976 Nov; 118(48):1571-4. PubMed ID: 826800 [TBL] [Abstract][Full Text] [Related]
32. Coronary artery disease: the use of monoamine oxidase inhibitors in the treatment of the anginal syndrome. FRIEDGOOD CE Angiology; 1960 Feb; 11():84-5. PubMed ID: 13825069 [No Abstract] [Full Text] [Related]
33. [Treatment with phenyl-propyl-diphenyl-propyl-amine (Segontin Hoechst) in coronary disease]. DOBREANU-ENESCU V; TEODORINI S; HARNAGEA P Stud Cercet Med Interna; 1963; 4():243-53. PubMed ID: 14028230 [No Abstract] [Full Text] [Related]
35. [USE OF MAO-INHIBITORS IN CORONARY ATHEROSCLEROSIS IN MAN AND IN EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS]. BOBKOVA VI; KHOVANSKAIA MG Ter Arkh; 1965 Jan; 37():27-32. PubMed ID: 14342989 [No Abstract] [Full Text] [Related]
36. [Results of a double blind study with Segontin-Digoxin in coronary heart disease (author's transl)]. Nossen J MMW Munch Med Wochenschr; 1977 Feb; 119(5):159-62. PubMed ID: 402569 [TBL] [Abstract][Full Text] [Related]
37. [Experiences with the clinical use of Segontin in coronary disease]. OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363 [No Abstract] [Full Text] [Related]
38. [A double-blind experiment with the coronary therapeutic agent segontin]. OVERKAMP H Med Klin; 1960 Aug; 55():1423-6. PubMed ID: 14429518 [No Abstract] [Full Text] [Related]
39. [Clinical experiences with segontin]. RATSCHOW M; SCHOOP W Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429 [No Abstract] [Full Text] [Related]
40. Pentaerythritol tetranitrate: a new drug for the treatment of coronary insufficiency. PLOTZ M N Y State J Med; 1952 Aug; 52(16):2012-5. PubMed ID: 13002777 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]